Abstract

Research Article

Clinical Severity of Sickle Cell Anaemia in Children in the Gambia: A Cross-Sectional Study

Lamin Makalo, Samuel A Adegoke, Stephen J Allen, Bankole P Kuti, Kalipha Kassama, Sheikh Joof, Aboulie Camara, Mamadou Lamin Kijera and Egbuna O Obidike

Published: 08 January, 2025 | Volume 9 - Issue 1 | Pages: 001-006

Background: Sickle cell anaemia (SCA) in children demonstrates a broad range of clinical manifestations and serious complications. Assessment of disease severity in specific populations is necessary to plan services and optimise care. 
Aim: To describe the clinical severity of SCA and associated sociodemographic and clinical factors in children in Gambia.
Methods: The presence of lifetime complications was confirmed by history and review of medical charts. We determined clinical severity using a validated scoring system and related the severity to sociodemographic and clinical factors.
Results: In 130 study participants, ages ranged from 5 to 15 years with a mean (SD) age of 9.74 (2.81) years. Eleven (8.5%) children had had acute chest syndrome, 7 (5.4%) avascular necrosis of the femoral head, 6 (4.6%) gallstones, 5 (3.8%) stroke and 1 (0.8%) priapism over their lifetime. Disease severity was classified as mild in 108 (83.1%) children, moderate in 17 (13.1%) and severe in 5 (3.8%). Age, age at diagnosis, sex, ethnicity, social class, and treatment with hydroxyurea was not significantly correlated with SCA clinical severity (P values 0.10-0.84).
Conclusion: The high proportion of children with mild disease may be due to the high prevalence of Senegalese β-haemoglobin haplotype in the Senegambia subregion. However, the presence of moderate or severe disease in almost 1 in 5 children calls for concerted efforts in SCD care in this region.

Read Full Article HTML DOI: 10.29328/journal.jhcr.1001033 Cite this Article Read Full Article PDF

Keywords:

Children; Gambia; Severity; Sickle cell disease

References

  1. Egesa WI, Nakalema G, Waibi WM, Turyasiima M, Amuje E, Kiconco G, et al. Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond. Int J Pediatr. 2022;2022:3885979. Available from: https://doi.org/10.1155/2022/3885979
  2. Inusa BPD, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, Anie KA, et al. Sickle Cell Disease-Genetics, Pathophysiology, Clinical Presentation and Treatment. Int J Neonatal Screen. 2019;5(2):20. Available from: https://doi.org/10.3390/ijns5020020
  3. Farrell AT, Panepinto J, Carroll CP, Darbari DS, Desai AA, King AA, et al. Endpoints for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain. Blood Adv. 2019;3(23):3982-4001. Available from: https://doi.org/10.1182/bloodadvances.2019000882
  4. Adegoke SA, Kuti BP. Evaluation of clinical severity of sickle cell anemia in Nigerian children. J Applied Hematol. 2013;4(2):58-64. Available from: https://www.researchgate.net/publication/255710803_Evaluation_of_Clinical_Severity_of_Sickle_Cell_Anaemia_in_Nigerian_Children
  5. Ballas SK, Lieff S, Benjamin LJ, Dampier CD, Heeney MM, Hoppe C, et al. Investigators, Comprehensive Sickle Cell Centers. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010;85(1):6-13. Available from: https://doi.org/10.1002/ajh.21550
  6. Bitoungui VJ, Pule GD, Hanchard N, Ngogang J, Wonkam A. Beta-globin gene haplotypes among Cameroonians and review of the global distribution: is there a case for a single sickle mutation origin in Africa? OMICS. 2015;19(3):171-9. Available from: https://doi.org/10.1089/omi.2014.0134
  7. Adeodu OO, Akinlosotu MA, Adegoke SA, Oseni SBA. Foetal Haemoglobin and Disease Severity in Nigerian Children with Sickle Cell Anaemia. Mediterr J Hematol Infect Dis. 2017;9(1):e2017063. Available from: https://doi.org/10.4084/MJHID.2017.063
  8. Mir R, Sharaf F, FM A. Hemoglobin Subunit Beta Gene Polymorphism rs33949930 T>C and Risk of Sickle Cell Disease—A Case-Control Study from Tabuk (Northwestern Part of Saudi Arabia). Int J Clin Med. 2016;7:25-31. Available from: https://www.scirp.org/journal/paperinformation?paperid=62941
  9. Ashley-Koch A, Yang Q, Onley RS. Sickle haemoglobin (HbS) Allele and Sickle Cell Disease: a HuGE Review. Am J Epidemiol. 2000;9:839-845. Available from: https://doi.org/10.1093/oxfordjournals.aje.a010288
  10. Adekile AD, Adeodu OO, Adegoke SA. Haemoglobinopathies. In: Azubuike JC, Nkanginieme KE, Ezechukwu C, Nte AR, Adedoyin AT, editors. Paediatrics and Child Health in a Tropical Region, 3rd edition. Lagos, Nigeria: Educational Printing and Publishing; 2017;1051–1065.
  11. Serjeant GR. Sickle Cell Disease. Lancet. 1997;350:725-730. Available from: https://doi.org/10.1016/s0140-6736(97)07330-3
  12. Okocha E, Onwubuya E, Osuji C, Ahaneku G, Okonkwo U. Disease Severity Scores and Haemogram Parameters in Nigerian Sickle Cell Disease Patients. J Blood Disord Transfus. 2015;6:324. Available from: https://www.walshmedicalmedia.com/open-access/disease-severity-scores-and-haemogram-parameters-in-nigerian-sickle-cell-disease-patients-2155-9864-1000324.pdf
  13. Adeodu OO, Akinlosotu MA, Adegoke SA, Oseni SBA. Foetal haemoglobin and disease severity in Nigerian children with sickle cell anaemia. Mediterr J Hematol Infect Dis. 2017;9(1):e2017063. Available from: https://doi.org/10.4084/MJHID.2017.063
  14. Adegoke SA, Adeodu OO, Adekile AD. Sickle cell disease clinical phenotypes in children from South-Western Nigeria. Niger J Clin Pract. 2015;18:95-101. Available from: https://doi.org/10.4103/1119-3077.146987
  15. Adeodu OO, Akinlosotu MA, Adegoke SA, Oseni SBA. Foetal haemoglobin and disease severity in Nigerian children with sickle cell anaemia. Mediterr J Hematol Infect Dis. 2017;9(1):e2017063. Available from: https://doi.org/10.4084/MJHID.2017.063
  16. Oladimeji OI, Adeodu OO, Onakpoya OH, Adegoke SA. Prevalence of ocular abnormalities in relation to sickle cell disease severity among children in South-western, Nigeria. Eur J Ophthalmol. 2021;31(5):2659-2665. Available from: https://doi.org/10.1177/1120672120957615
  17. Ogunlesi TA, Dedeke IOF, Kuponiyi OT. Socio-economic classification of children attending Specialist paediatric centres in Ogun State, Nigeria. Niger Med Pract. 2008;54(1):21-25. Available from: https://www.ajol.info/index.php/nmp/article/view/28943
  18. el-Hazmi MA. Clinical and haematological diversity of sickle cell disease in Saudi children. J Trop Pediatr. 1992;38:106-12. Available from: https://doi.org/10.1093/tropej/38.3.106
  19. Al-Saqladi AM, Delpisheh A, Bin-Gadeem HA, Brabin BJ. Severity of sickle cell disease in Yemeni children. J Trop Pediatr. 2009;55:208-9. Available from: https://doi.org/10.1093/tropej/fmn109
  20. Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011;31:289-293. Available from: https://doi.org/10.4103/0256-4947.81540
  21. Ballas SK. Effect of alpha-globin genotype on the pathophysiology of sickle cell disease. Pediatr Pathol Mol Med. 2001;20:107-21. Available from: https://pubmed.ncbi.nlm.nih.gov/12673836/
  22. McGann PT. Time to Invest in Sickle Cell Anemia as a Global Health Priority. Pediatrics. 2016;137(6):e20160348. Available from: https://doi.org/10.1542/peds.2016-0348
  23. Ballas SK, Barton FB, Waclawiw MA, Swerdlow P, Eckman JR, Pegelow CH, et al. Hydroxyurea and sickle cell anemia: effect on quality of life. Health Qual Life Outcomes. 2006;4:59. Available from: https://doi.org/10.1186/1477-7525-4-59

Figures:

Figure 1

Figure 1

Similar Articles

  • Cytomegalovirus pneumonia and Cryptogenic organizing pneumonia following pediatric stem cell transplantation for leukemia
    Zühre Kaya*, Tuba Şişmanlar, Ayşe Tana Aslan, Öznur Konuş Boyunağa, Işıl Fidan Balcı, İdil Yenicesu and Ülker Koçak Zühre Kaya*,Tuba Şişmanlar,Ayşe Tana Aslan,Öznur Konuş Boyunağa,Işıl Fidan Balcı,İdil Yenicesu,Ülker Koçak. Cytomegalovirus pneumonia and Cryptogenic organizing pneumonia following pediatric stem cell transplantation for leukemia. . 2017 doi: 10.29328/journal.jhcr.1001003; 1: 014-018
  • Using the DFConhecimento instrument to assess Congolese healthcare professionals’ knowledge on sickle cell disease
    Tina Katamea, Olivier Mukuku, Patient Dinanga Nzala, Bénédicte Malonda Nsasi, Charles Wembonyama Mpoy, Oscar Numbi Luboya and Stanis Okitotsho Wembonyama* Tina Katamea,Olivier Mukuku,Patient Dinanga Nzala,Bénédicte Malonda Nsasi,Charles Wembonyama Mpoy,Oscar Numbi Luboya,Stanis Okitotsho Wembonyama*. Using the DFConhecimento instrument to assess Congolese healthcare professionals’ knowledge on sickle cell disease. . 2021 doi: 10.29328/journal.jhcr.1001018; 5: 015-020
  • Clinical Severity of Sickle Cell Anaemia in Children in the Gambia: A Cross-Sectional Study
    Lamin Makalo, Samuel A Adegoke, Stephen J Allen, Bankole P Kuti, Kalipha Kassama, Sheikh Joof, Aboulie Camara, Mamadou Lamin Kijera and Egbuna O Obidike Lamin Makalo,Samuel A Adegoke,Stephen J Allen,Bankole P Kuti,Kalipha Kassama,Sheikh Joof,Aboulie Camara,Mamadou Lamin Kijera,Egbuna O Obidike. Clinical Severity of Sickle Cell Anaemia in Children in the Gambia: A Cross-Sectional Study. . 2025 doi: 10.29328/journal.jhcr.1001033; 9: 001-006

Recently Viewed

Read More

Most Viewed

Read More

Help ?